Genacept was formed to bring innovative new products to market. Most creative concepts, good ideas and even inventions won’t develop into successful commercial products. Innovation requires a rare combination of a novel capability that solves a significant market need, favorable economics, supply chain excellence, commercialization excellence and leadership and talent. Genacept leverages decades of research, development and commercialization experience to screen and select commercially viable technical breakthroughs and translate them into competitively advantaged new products.
Three tools Genacept employs are:
- Stage-Gate Development Process – Our structured, disciplined approach focuses on speed, milestone achievements, and iterative designs to ensure the final product is truly innovative.
- Evidence-Based Vetting – Beginning with a detailed set of assumptions regarding the elements that must be in place for a concept to become an innovation, every stage of development involves obtaining data (e.g. customer insights, regulatory feedback, vendor quotes, etc.) to affirm or refute those assumptions.
- Valuation Analysis – Funding is the lifeblood necessary for a novel concept to become an innovation in the market. Investors must be provided a clear and comprehensive view of the concept’s value and financial drivers throughout the development process.
